201 related articles for article (PubMed ID: 29613987)
1. Focal Myocardial Damage in Cardiac Sarcoidosis Characterized by Strain Analysis on Magnetic Resonance Tagged Imaging in Comparison with Fluorodeoxyglucose Positron Emission Tomography Accumulation and Magnetic Resonance Late Gadolinium Enhancement.
Watanabe Y; Nishii T; Shimoyama S; Ito T; Mori S; Kono AK; Takahashi S; Hirata KI; Sugimura K
J Comput Assist Tomogr; 2018; 42(4):607-613. PubMed ID: 29613987
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
[TBL] [Abstract][Full Text] [Related]
3. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
Rischpler C; Langwieser N; Souvatzoglou M; Batrice A; van Marwick S; Snajberk J; Ibrahim T; Laugwitz KL; Nekolla SG; Schwaiger M
Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.
Matsumoto K; Ehara S; Sakaguchi M; Otsuka K; Hasegawa T; Shimada K; Yoshiyama M
Osaka City Med J; 2015 Jun; 61(1):9-17. PubMed ID: 26434101
[TBL] [Abstract][Full Text] [Related]
6. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
Kataoka S; Momose M; Fukushima K; Serizawa N; Suzuki A; Kondo C; Abe K; Sakai S; Hagiwara N
Ann Nucl Med; 2017 Feb; 31(2):135-143. PubMed ID: 27804054
[TBL] [Abstract][Full Text] [Related]
7. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of fusion
Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
[TBL] [Abstract][Full Text] [Related]
9. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
Trivieri MG; Robson PM; Vergani V; LaRocca G; Romero-Daza AM; Abgral R; Devesa A; Azoulay LD; Karakatsanis NA; Parikh A; Panagiota C; Palmisano A; DePalo L; Chang HL; Rothstein JH; Fayad RA; Miller MA; Fuster V; Narula J; Dweck MR; Morgenthau A; Jacobi A; Padilla M; Kovacic JC; Fayad ZA
JACC Cardiovasc Imaging; 2024 Apr; 17(4):411-424. PubMed ID: 38300202
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging.
Bravo PE; Raghu G; Rosenthal DG; Elman S; Petek BJ; Soine LA; Maki JH; Branch KR; Masri SC; Patton KK; Caldwell JH; Krieger EV
Int J Cardiol; 2017 Aug; 241():457-462. PubMed ID: 28318664
[TBL] [Abstract][Full Text] [Related]
11. Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography.
Spinelli L; Imbriaco M; Nappi C; Nicolai E; Giugliano G; Ponsiglione A; Diomiaiuti TC; Riccio E; Duro G; Pisani A; Trimarco B; Cuocolo A
Circ Cardiovasc Imaging; 2018 Apr; 11(4):e007019. PubMed ID: 29626078
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
Tanaka TD; Nagai T; Nagoshi T; Yoshimura M
J Nucl Cardiol; 2020 Dec; 27(6):2149-2153. PubMed ID: 31773564
[TBL] [Abstract][Full Text] [Related]
13. Comparison of (99m)Tc-MIBI SPECT/18F-FDG PET imaging and cardiac magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy: assessment of cardiac function and myocardial injury.
Wang L; Yan C; Zhao S; Fang W
Clin Nucl Med; 2012 Dec; 37(12):1163-9. PubMed ID: 23154474
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
15. Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis.
Sharp MB; Soufer A; Abdelmessih M; Rosenfeld LE; Baldassarre LA; Miller EJ
J Nucl Cardiol; 2020 Apr; 27(2):688-690. PubMed ID: 30737635
[No Abstract] [Full Text] [Related]
16. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.
Sgard B; Brillet PY; Bouvry D; Djelbani S; Nunes H; Meune C; Valeyre D; Soussan M
Clin Radiol; 2019 Jan; 74(1):81.e9-81.e18. PubMed ID: 30482560
[TBL] [Abstract][Full Text] [Related]
17. Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by
Sasson SC; Russo R; Chung T; Chu G; Hunyor I; Williamson J; Murad A; Kane A; Riminton S; Limaye S
J Med Case Rep; 2017 Oct; 11(1):291. PubMed ID: 29052526
[TBL] [Abstract][Full Text] [Related]
18. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
[TBL] [Abstract][Full Text] [Related]
19. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography in comparison to late gadolinium enhancement cardiac magnetic resonance for analysis of myocardial fibrosis in severe aortic stenosis.
Hoffmann R; Altiok E; Friedman Z; Becker M; Frick M
Am J Cardiol; 2014 Oct; 114(7):1083-8. PubMed ID: 25212549
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
